| 내 용 |
magic story very thanks http://mijnnn.icu nn honeys Celgene Corp, up 7 percent to $133.86, was amongthe top performers for both the S&P 500 and the Nasdaq 100 after the company said a late-stage trial of its cancerdrug Revlimid met the main goal of improving survival in newlydiagnosed blood cancer patients.
|
